Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clark D Russell

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
The Lancet. Digital Health|March 26, 2022
Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort studyFiina Närhi, S Ramani Moonesinghe, Susan D Shenkin, et al.
Science Immunology|March 11, 2021
Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19Ryan S Thwaites, Ashley Sanchez Sevilla Uruchurtu, Matthew K Siggins, et al.
BMJ (Clinical Research Ed.)|May 24, 2020
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort studyAnnemarie B Docherty, Ewen M Harrison, Christopher A Green, et al.
American Journal of Respiratory and Critical Care Medicine|November 20, 2020
Tissue-Specific Immunopathology in Fatal COVID-19David A Dorward, Clark D Russell, In Hwa Um, et al.
The Lancet. Respiratory Medicine|May 17, 2021
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UKAnnemarie B Docherty, Rachel H Mulholland, Nazir I Lone, et al.
The Lancet Regional Health. Europe|August 13, 2021
Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation ProtocolLouise Sigfrid, Thomas M Drake, Ellen Pauley, et al.
BMJ Open|March 11, 2021
What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocolLouise Sigfrid, Muge Cevik, Edwin Jesudason, et al.
Lancet (London, England)|July 18, 2021
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort studyThomas M Drake, Aya M Riad, Cameron J Fairfield, et al.
BMJ (Clinical Research Ed.)|September 10, 2020
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality ScoreStephen R Knight, Antonia Ho, Riinu Pius, et al.
Thorax|November 23, 2021
Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation ProtocolStephen R Knight, Rishi K Gupta, Antonia Ho, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
The Lancet. Digital Health|March 26, 2022
Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort studyFiina Närhi, S Ramani Moonesinghe, Susan D Shenkin, et al.
Science Immunology|March 11, 2021
Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19Ryan S Thwaites, Ashley Sanchez Sevilla Uruchurtu, Matthew K Siggins, et al.
BMJ (Clinical Research Ed.)|May 24, 2020
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort studyAnnemarie B Docherty, Ewen M Harrison, Christopher A Green, et al.
American Journal of Respiratory and Critical Care Medicine|November 20, 2020
Tissue-Specific Immunopathology in Fatal COVID-19David A Dorward, Clark D Russell, In Hwa Um, et al.
The Lancet. Respiratory Medicine|May 17, 2021
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UKAnnemarie B Docherty, Rachel H Mulholland, Nazir I Lone, et al.
The Lancet Regional Health. Europe|August 13, 2021
Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation ProtocolLouise Sigfrid, Thomas M Drake, Ellen Pauley, et al.
BMJ Open|March 11, 2021
What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocolLouise Sigfrid, Muge Cevik, Edwin Jesudason, et al.
Lancet (London, England)|July 18, 2021
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort studyThomas M Drake, Aya M Riad, Cameron J Fairfield, et al.
BMJ (Clinical Research Ed.)|September 10, 2020
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality ScoreStephen R Knight, Antonia Ho, Riinu Pius, et al.
Thorax|November 23, 2021
Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation ProtocolStephen R Knight, Rishi K Gupta, Antonia Ho, et al.
Pageof 9